BridgeMD
New treatment option for Ureteral Stones
Official title Evaluating Postoperative Pain After Ureterorenoscopy.
ClinicalTrials.gov ID: NCT07283003
What this study is testing
- What it's testing
- Comparison of routine postoperative stenting versus no stenting after ureterorenoscopy for ureteral stones to assess the necessity and impact on complication risk.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Patients with ureteral stones scheduled for ureteroscopy (URS) and stone removal
- Previous pre-stenting
- Informed Consent as documented
You likely can't join if
- Complex ureteral conditions (e.g., known ureteral strictures)
- Impacted stones
- Solitary kidney
- Patients with significant renal stones (\>3mm)
- Previous ureteral surgeries (except endoscopic stone treatments)
- Pregnancy or suspected pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Baden, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baden, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.